These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28559969)

  • 21. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.
    Yang C; He L; Chen G; Ning Z; Xia Z
    Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
    Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF
    Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular cholesterol level regulates sensitivity of glioblastoma cells against temozolomide-induced cell death by modulation of caspase-8 activation via death receptor 5-accumulation and activation in the plasma membrane lipid raft.
    Yamamoto Y; Tomiyama A; Sasaki N; Yamaguchi H; Shirakihara T; Nakashima K; Kumagai K; Takeuchi S; Toyooka T; Otani N; Wada K; Narita Y; Ichimura K; Sakai R; Namba H; Mori K
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1292-1299. PubMed ID: 29162448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
    Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment.
    Chen Y; Gao F; Jiang R; Liu H; Hou J; Yi Y; Kang L; Liu X; Li Y; Yang M
    J Cell Biochem; 2017 Dec; 118(12):4905-4913. PubMed ID: 28569417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [RAD51 promotes proliferation and migration of glioblastoma cells and decreases sensitivity of cells to temozolomide].
    Li Q; Ru Y; Wang Q; Lyu W; Hu W; Fei Z; Li X; Lin W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Sep; 35(9):817-822. PubMed ID: 31750824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of IFN-beta on human glioma cell lines with temozolomide resistance.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E
    Int J Oncol; 2009 Jul; 35(1):139-48. PubMed ID: 19513561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
    Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
    Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo.
    Eom KY; Cho BJ; Choi EJ; Kim JH; Chie EK; Wu HG; Kim IH; Paek SH; Kim JS; Kim IA
    Cancer Res Treat; 2016 Apr; 48(2):687-97. PubMed ID: 26044161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence.
    Berte N; Lokan S; Eich M; Kim E; Kaina B
    Oncotarget; 2016 Oct; 7(41):67235-67250. PubMed ID: 27626497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.
    Kumar DM; Patil V; Ramachandran B; Nila MV; Dharmalingam K; Somasundaram K
    Proteomics; 2013 Jul; 13(14):2113-24. PubMed ID: 23595970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
    He Y; Kaina B
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas.
    Kipper FC; Silva AO; Marc AL; Confortin G; Junqueira AV; Neto EP; Lenz G
    Invest New Drugs; 2018 Apr; 36(2):323-331. PubMed ID: 28852916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of sonodynamic with temozolomide inhibits C6 glioma migration and promotes mitochondrial pathway apoptosis via suppressing NHE-1 expression.
    Chen L; Cong D; Li Y; Wang D; Li Q; Hu S
    Ultrason Sonochem; 2017 Nov; 39():654-661. PubMed ID: 28732990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling predicts response to temozolomide in malignant gliomas.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E; Tsumoto K
    Int J Oncol; 2010 Jun; 36(6):1367-77. PubMed ID: 20428759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
    Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
    J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.
    Wang H; Ren S; Xu Y; Miao W; Huang X; Qu Z; Li J; Liu X; Kong P
    Anticancer Drugs; 2019 Jan; 30(1):81-88. PubMed ID: 30273182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.
    Stritzelberger J; Distel L; Buslei R; Fietkau R; Putz F
    Clin Transl Oncol; 2018 Apr; 20(4):508-516. PubMed ID: 28825189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.